Biotech

All Articles

F 2G increases $100M for second try to acquire new antifungal to market

.After F2G's 1st attempt to acquire a brand-new lesson of antifungal to market was hindered by the F...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 plans in the middle of success tensions

.Moderna has actually vowed to cut R&ampD costs through $1.1 billion by 2027. The choice to retract ...

Sanofi's $80M bet on Fulcrum dystrophy drug ends in period 3 go belly up

.Merely 4 months after Sanofi wager $80 thousand in ahead of time cash money on Key Therapeutics' lo...

Oncternal stock drains 60% amid unemployments, test terminations

.Cancer cells company Oncternal Rehabs is folding all its professional trials and laying off team, s...

Novo Nordisk hails 'remarkable' weight reduction lead for dual-acting oral drug in very early test

.Novo Nordisk has actually raised the lid on a phase 1 test of its oral amylin and also GLP-1 recept...

AbbVie sues BeiGene over blood stream cancer drug proprietary knowledge

.Only a handful of quick weeks after winning an FDA Fast lane tag for its investigational BTK degrad...

Lilly delivers one-two punch with 2nd tranche of favorable data on regular insulin candidate

.Quickly after a positive data drop for Eli Lilly's efsitora alfa, the Indianapolis-based company is...

BridgeBio cuts genetics therapy budget as medical data let down

.BridgeBio Pharma is actually lowering its genetics therapy budget and drawing back from the techniq...

GSK gives up HSV injection wishes after period 2 stop working, ceding ethnicity to Moderna, BioNTech

.GSK's attempt to establish the 1st vaccine for genital herpes simplex infection (HSV) has actually ...